Literature DB >> 14059292

EFFECT OF PENICILLIN TREATMENT ON SERUM COMPLEMENT LEVELS IN ACUTE RHEUMATIC FEVER.

A F SCHUBART, H J ROTHSCHILD, W C SCHROEDER, R W EWALD, J D TUERK.   

Abstract

Entities:  

Keywords:  ASPIRIN; COMPLEMENT; ERYTHROMYCIN; PENICILLIN; RHEUMATIC FEVER; STREPTOCOCCAL INFECTIONS; SULFADIAZINE

Mesh：

Substances：

Year:  1963        PMID： 14059292      PMCID： PMC1030863          DOI： 10.1136/ard.22.5.319

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Alleged anticomplementary effect of aspirin.

Authors:  K W ANDERSON
Journal:  Nature       Date:  1961-09-02       Impact factor: 49.962

2.  Anticomplementary action of aspirin.

Authors:  C van OSS; J C FRIEDMANN; M FONTAINE
Journal:  Nature       Date:  1961-01-14       Impact factor: 49.962

3.  Observations on the treatment of rheumatic fever with salicylate, ACTH and cortisone. II. Combined salicylate and corticoid therapy and attempts at rebound suppression.

Authors:  E E FISCHEL; C W FRANK; A J BOLTAX; M ARCASOY
Journal:  Arthritis Rheum       Date:  1958-08

4.  Serum complement in connective tissue disorders.

Authors:  R C WILLIAMS; D H LAW
Journal:  J Lab Clin Med       Date:  1958-08

5.  Serum complement in children with collagen diseases.

Authors:  R J P WEDGWOOD; C A JANEWAY
Journal:  Pediatrics       Date:  1953-06       Impact factor: 7.124

6.  SEROLOGICAL STUDIES IN RHEUMATIC FEVER. II. SERUM COMPLEMENT IN THE RHEUMATIC STATE.

Authors:  E E Fischel; R H Pauli; J Lesh
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808
  6 in total
  1 in total

1.  Serum complement levels in rheumatoid arthritis. A longitudinal study of 43 cases with correlation of clinical and serological data including rheumatoid factor and thermolabile inhibitor of the F-II L.P. test.

Authors:  A F Schubart; R W Ewald; W C Schroeder; H J Rothschild; D N Bhatavadekar; P K Pullen
Journal:  Ann Rheum Dis       Date:  1965-09       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.